Oxonica

About:

Oxonica develops and commercializes advanced nanomaterials for UV protection, security, and biodiagnostics applications.

Website: http://www.oxonica.com

Top Investors: Foresight Group, Oxford Capital, Quester, Income & Growth VCT, Richard Farleigh

Description:

Oxonica Plc engages in the development and commercialization of advanced nanomaterials UV protection, security, and biodiagnostics applications. It also engages in the development, sale, marketing, and supply of fuel additive products. The company offers ENVIROX fuel combustion catalyst, a diesel fuel additive that reduces fuel consumption, greenhouse gas emissions, and other harmful exhaust emissions; and OPTISOL UV absorber, which provides spectrum protection for personal care products. It also provides SOLACOR, a UV absorber for plastics, polymers, coatings, and textile applications; and NANOPLEX biomarker detection platform that enables the detection of various disease markers, providing clinical laboratory performance and real time information at the point of care. In addition, the company offers brand protection and anti-counterfeiting solutions, as well as Sol-ID taggants, a series of nanoscale optical labels that generate fingerprint-like signatures. Oxonica Plc is headquartered in Kidlington, the United Kingdom.

Total Funding Amount:

12.2M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Haddenham, Cambridgeshire, United Kingdom

Founded Date:

2005-01-01

Contact Email:

info(AT)oxonica.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2007-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai